{"transactions":[{"id":1168335,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2025-04-21T20:44:41.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% will vest on April 17, 2026, and the remaining 75% will vest in 12 equal quarterly installments."}],"balance_after":250000,"derivative":{"exercise_price":0.5796,"expiration_date":"2035-04-16","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001837830-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783025000002/primary_doc.xml","form_type":"4"}},{"id":1176621,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-07T20:47:21.000Z","date":"2025-04-04","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":0.5,"value":100000.0,"ownership":{"direct":true},"balance_after":444117,"source":{"system":"sec-edgar","filing":"0001837830-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783025000001/primary_doc.xml","form_type":"4"}},{"id":1578031,"issuer":{"id":7909,"kind":"organization","name":"Healthcare Triangle, Inc."},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Incentive Stock Option (Right To Buy)","published_at":"2024-03-13T17:00:07.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Incentive stock option granted 03/12/2024 under the Company's 2020 Stock Incentive Plan. All options expire within a 5-year period, with all 5,000 options vesting immediately."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 26, 2023, the Issuer effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Split\"). Unless otherwise noted, the amount of securities and purchase prices reported on this Form 4 have been adjusted to reflect the Reverse Split."}],"balance_after":10000,"derivative":{"exercise_price":1.78,"exercise_date":"2024-03-12","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001213900-24-022218","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837830/000121390024022218/ownership.xml","form_type":"4"}},{"id":1629133,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-21T15:57:18.000Z","date":"2024-02-18","kind":"grant","planned":false,"acquired":true,"shares":113717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":244117,"source":{"system":"sec-edgar","filing":"0001837830-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783024000001/primary_doc.xml","form_type":"4"}},{"id":1743922,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T22:53:17.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":89283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% will vest on November 9, 2024, and the remaining 75% will vest in 36 equal monthly installments on the last day of each month following November 9, 2024."}],"balance_after":89283,"derivative":{"exercise_price":1.25,"expiration_date":"2033-11-08","underlying":"Common Stock","underlying_shares":89283},"source":{"system":"sec-edgar","filing":"0001837830-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783023000003/primary_doc.xml","form_type":"4"}},{"id":1781023,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-14T15:36:45.000Z","date":"2023-09-13","kind":"purchase","planned":false,"acquired":true,"shares":50900,"price":0.9828,"value":50024.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $0.9525 to $0.9893 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":130400,"source":{"system":"sec-edgar","filing":"0001837830-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783023000002/primary_doc.xml","form_type":"4"}},{"id":1914137,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-04-25T19:39:59.000Z","date":"2023-04-21","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% will vest on April 21, 2024 and the remaining 75% will vest in 12 equal quarterly installments on the last day of each quarter beginning on June 30, 2024."}],"balance_after":12500,"derivative":{"exercise_price":1.59,"expiration_date":"2033-04-20","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001837830-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783023000001/primary_doc.xml","form_type":"4"}},{"id":1914136,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-25T19:39:59.000Z","date":"2023-04-21","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments on the last day of each quarter over the next 8 quarters, subject to continued service on such vesting date."}],"balance_after":79500,"source":{"system":"sec-edgar","filing":"0001837830-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783023000001/primary_doc.xml","form_type":"4"}},{"id":2229919,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-16T13:54:50.000Z","date":"2022-06-15","kind":"purchase","acquired":true,"shares":10000,"price":1.0219,"value":10219.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $0.9278 to $1.0599 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":67000,"source":{"system":"sec-edgar","filing":"0001837830-22-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783022000004/primary_doc.xml","form_type":"4"}},{"id":2232635,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-14T20:16:52.000Z","date":"2022-06-10","kind":"purchase","acquired":true,"shares":14000,"price":1.0558,"value":14781.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $1.02 to $1.0888 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":57000,"source":{"system":"sec-edgar","filing":"0001837830-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783022000003/primary_doc.xml","form_type":"4"}},{"id":2258231,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-24T20:03:17.000Z","date":"2022-05-24","kind":"purchase","acquired":true,"shares":10500,"price":0.9801,"value":10291.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $0.9174 to $1.00 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":43000,"source":{"system":"sec-edgar","filing":"0001837830-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783022000002/primary_doc.xml","form_type":"4"}},{"id":2258230,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-24T20:03:17.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":17500,"price":0.8528,"value":14924.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $0.80 to $0.878 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":32500,"source":{"system":"sec-edgar","filing":"0001837830-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783022000002/primary_doc.xml","form_type":"4"}},{"id":2411670,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-04T23:37:47.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments on the last day of each month over the next 24 months, subject to continued service on such vesting date."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001837830-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000183783022000001/primary_doc.xml","form_type":"4"}},{"id":2890278,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2021-01-29T22:10:35.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% will vest on January 27, 2022 and remaining 75% will vest in 36 equal monthly installments on the last day of each month beginning on February 28, 2022."}],"balance_after":140000,"derivative":{"exercise_price":1.99,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001596771-21-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000159677121000007/primary_doc.xml","form_type":"4"}},{"id":2920449,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":80632,"kind":"person","name":"McClurg Ronald W.","position":1,"cik":"0001837830","reported_name":"McClurg Ronald W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2021-01-05T19:41:56.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% will vest on January 1, 2022 and the remaining 75% will vest in 36 equal monthly installments beginning on February 1, 2022."}],"balance_after":180000,"derivative":{"exercise_price":1.57,"expiration_date":"2031-01-01","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001213900-21-000388","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390021000388/ownership.xml","form_type":"4"}}]}